Toshikatsu Kaburaki Selected Research

Therapeutics

1/2020	Comparisons of Clinical Features in Japanese Patients with Behçet's Uveitis Treated in the 1990s and the 2000s.
1/2020	Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial.
3/2019	Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.
1/2018	Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
10/2014	Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
3/2014	Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab.
11/2012	Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.
4/2012	Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshikatsu Kaburaki Research Topics

Disease

24	Uveitis 06/2022 - 11/2003
11	Inflammation (Inflammations) 06/2022 - 11/2003
11	Sarcoidosis (Schaumann Disease) 03/2022 - 12/2009
6	Panuveitis 06/2022 - 01/2018
6	Endophthalmitis (Ophthalmia) 03/2020 - 03/2006
5	Glaucoma 03/2022 - 07/2017
5	Acute Retinal Necrosis Syndrome 01/2021 - 01/2019
4	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 06/2022 - 01/2019
4	Cataract (Cataracts) 01/2022 - 10/2005
4	Infections 01/2021 - 04/2010
3	Macular Edema 06/2022 - 07/2015
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2021 - 01/2021
3	Vision Disorders (Hemeralopia) 04/2021 - 02/2020
3	Anterior Uveitis 01/2021 - 01/2013
3	Iridocyclitis 01/2020 - 08/2012
3	Scleritis (Episcleritis) 07/2018 - 01/2018
3	Abscess 09/2015 - 04/2010
2	Lymphoma (Lymphomas) 08/2022 - 03/2018
2	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2011
2	Fibrosis (Cirrhosis) 06/2021 - 04/2010
2	Posterior Uveitis 01/2021 - 02/2020
2	Rheumatoid Arthritis 03/2020 - 07/2018
2	Retinitis 03/2020 - 08/2018
2	Intraocular Lymphoma 01/2020 - 04/2012
2	Behcet Syndrome (Behcet's Syndrome) 07/2017 - 05/2003
2	Choroidal Neovascularization 01/2016 - 04/2012
1	Drug-Related Side Effects and Adverse Reactions 03/2022
1	Toxic Optic Neuropathy 01/2022
1	Disease Progression 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Ulcer 06/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Intermediate Uveitis (Chronic Cyclitis) 01/2021
1	Familial Exudative Vitreoretinopathies 01/2021
1	Cytomegalovirus Retinitis 03/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2020
1	Multiple Sclerosis 03/2020
1	Sympathetic Ophthalmia (Sympathetic Uveitis) 03/2020
1	Arteritis 03/2020
1	Collagen Diseases (Collagen Disease) 03/2020
1	Arthritis (Polyarthritis) 02/2020
1	Myopia 01/2020
1	Pseudophakia 01/2020
1	Choroiditis 01/2019
1	Hyperemia 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 01/2019
1	Chorioretinitis 01/2019

Drug/Important Bio-Agent (IBA)

11	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 11/2003
6	Adalimumab (Humira)FDA Link 06/2022 - 01/2018
5	Retinaldehyde (Retinal)IBA 06/2022 - 01/2019
5	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 07/2015
5	Infliximab (Remicade)FDA Link 01/2020 - 11/2012
3	SteroidsIBA 03/2022 - 01/2018
3	Betamethasone (Celestone)FDA Link 06/2021 - 08/2012
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
3	ChemokinesIBA 01/2020 - 05/2003
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019 - 01/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 04/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2021 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 06/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2021 - 11/2020
2	HLA-B Antigens (HLA-B)IBA 02/2020 - 01/2019
2	HLA-A Antigens (HLA-A)IBA 02/2020 - 07/2010
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 04/2012
2	Ophthalmic Solutions (Eye Drops)IBA 03/2019 - 08/2012
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2019 - 01/2013
1	InterleukinsIBA 08/2022
1	Immunoglobulins (Immunoglobulin)IBA 08/2022
1	CrizotinibIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 06/2021
1	Intergenic DNA (Junk DNA)IBA 01/2021
1	NucleotidesIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2020
1	Chemokine CCL5IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	SolutionsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	CytokinesIBA 01/2020
1	Atropine FDA LinkGeneric 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2020 - 04/2012
7	Vitrectomy 01/2022 - 03/2006
4	Drug Therapy (Chemotherapy) 04/2021 - 12/2011
2	Trabeculectomy (Trabeculoplasty) 06/2021 - 07/2017
2	Liver Transplantation 02/2018 - 04/2010
2	Slit Lamp 01/2018 - 04/2010
2	Injections 09/2015 - 01/2013
2	Radiotherapy 04/2012 - 12/2011
1	Intraocular Lenses (Intraocular Lens) 01/2022
1	Scleral Buckling 01/2022
1	Descemet Stripping Endothelial Keratoplasty 06/2021
1	Corneal Transplantation (Keratoplasty) 06/2021
1	Topical Administration 03/2019